Key result
A new method for measuring heparin utilizing its potentiating effect on anti-factor Xa was described and compared with the calcium thrombin time method in obstetrical patients.
Why the study?
How does an anti-factor Xa-based heparin measurement method compare to the calcium thrombin time method in obstetrical patients?
How does an anti-factor Xa-based heparin measurement method compare to the calcium thrombin time method in obstetrical patients?
The study describes a method for measuring heparin using anti-factor Xa and compares it with the calcium thrombin time method.
Answers are grounded in this paper and cite their sources.
Anti-Xa heparin assay may support monitoring in obstetrical patients; leaves open superiority over calcium thrombin time pending validation.
Summary A method for the measurement of heparin utilising the potentiating effect of heparin on the action of anti-factor Xa is described. The effect on the assay of platelet contamination of plasma, the presence of fibrinogen degradation products and low levels of anti-factor Xa have been studied. The assay method has been compared with the calcium thrombin time method and a group of obstetrical patients have been studied using both methods.
No takes yet. Share an insight, caveat, or question.
Denson et al. (1973) studied Obstetrical patients. Anti-factor Xa assay for heparin measurement vs. Calcium thrombin time method was evaluated on Assay comparison. A new method for measuring heparin utilizing its potentiating effect on anti-factor Xa was described and compared with the calcium thrombin time method in obstetrical patients.
Synapse has enriched 10 related papers. Consider them for comparative context: